-- 
Keyware, Nyrstar, Telegraaf, Vopak: Benelux Equity Preview

-- B y   M a u d   v a n   G a a l   a n d   J o h n   M a r t e n s
-- 
2011-03-11T05:00:01Z

-- http://www.bloomberg.com/news/2011-03-11/keyware-nyrstar-telegraaf-vopak-benelux-equity-preview.html
The following companies may have
unusual price changes in Benelux markets. Stock symbols are in
parentheses, and prices are from the previous close.  The  AEX-Index (AEX)  in Amsterdam declined 4.11, or 1.1 percent,
to 362.14.  Belgium ’s Bel20 Index fell 9.41, or 0.4 percent, to
2,666.24. Luxembourg’s LuxX Index lost 0.2 percent to 1,460.07.  Dutch stocks:    Telegraaf Media Groep NV (TELEG)  : The Dutch newspaper
publisher may report full-year profit excluding some items of
52.9 million euros ($73.1 million), according to the average of
four analyst estimates compiled by Bloomberg. Telegraaf rose 0.1
percent to 14.32 euros.  Royal Vopak NV (VPK NA): The world’s largest chemical and
oil storage company may report full-year net income rose to
276.8 million euros, according to the average estimate of nine
analysts surveyed by Bloomberg. Vopak retreated 0.9 percent to
34.78 euros.  Belgian stocks:    Keyware Technologies NV (KEYW)  : The Belgian supplier of
electronic payment terminals reported full-year net income of
446,000 euros and expects an outcome of takeover talks with an
undisclosed number of industrial partners during the third
quarter. Keyware climbed 2.3 percent to 1.77 euros.    Nyrstar (NYR)  NV: Existing investors in the world’s
largest producer of refined zinc have until 4 p.m. in Brussels
to buy seven new shares at 7 euros apiece for every 10 they
hold. Nyrstar lost 2.5 percent to 9.91 euros. The subscription
rights (NYR3 BB) fell 8.6 percent to 2.01 euros.    ThromboGenics NV (THR)  : The Belgian developer of the
microplasmin retinal-disorder medicine said it plans to seek
U.S. and European regulatory approval for the experimental drug
in the second half of 2011. The company had 109.2 million euros
of cash and short-term investments on Dec. 31. The shares
dropped 0.8 percent to 20.69 euros.  To contact the reporters on this story:
Maud van Gaal in Amsterdam at 
 mvangaal@bloomberg.net ;
John Martens in Brussels at 
 jmartens1@bloomberg.net   To contact the editors responsible for this story:
Frank Connelly at   fconnelly@bloomberg.net ;
Angela Cullen at   acullen8@bloomberg.net  